Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax

Affiliations

• ¹ Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
• ² German Center for Child and Adolescent Health (DZKJ), partner site Ulm, Ulm, Germany.
• ³ Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
• ⁴ Clinical Genetics and Genomic Medicine, University Hospital Würzburg, Würzburg, Germany.
• ⁵ Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.
• ⁶ Clinic for Pediatric Oncology and Rheumatology (Children and Adolescent Medicine I), University Hospital Schleswig-Holstein, Kiel, Germany.
• ⁷ Internal Medicine II-Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
• ⁸ Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.
• ⁹ Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany. klaus-michael.debatin@uniklinik-ulm.de.
• ¹⁰ German Center for Child and Adolescent Health (DZKJ), partner site Ulm, Ulm, Germany. klaus-michael.debatin@uniklinik-ulm.de.